Filing Details
- Accession Number:
- 0001179110-13-015521
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-15 16:32:30
- Reporting Period:
- 2013-04-30
- Filing Date:
- 2013-10-15
- Accepted Time:
- 2013-10-15 16:32:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
21510 | Coherent Inc | COHR | Laboratory Analytical Instruments (3826) | 941622541 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1234301 | John Ambroseo | P.o. Box 54980 Santa Clara CA 95056-0980 | Pres. And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-04-30 | 593 | $42.13 | 137,843 | No | 5 | J | Indirect | Family Trust |
Common Stock | Acquisiton | 2013-10-11 | 25,200 | $23.16 | 163,043 | No | 4 | M | Indirect | Family Trust |
Common Stock | Disposition | 2013-10-11 | 25,200 | $64.04 | 137,843 | No | 4 | S | Indirect | Family Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | J | Indirect | Family Trust |
No | 4 | M | Indirect | Family Trust |
No | 4 | S | Indirect | Family Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non Qualified Stock Option (right to buy) | Disposition | 2013-10-11 | 25,200 | $0.00 | 25,200 | $23.16 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
223,998 | 2014-11-17 | No | 4 | M | Direct |
Footnotes
- Purchase under employee stock purchase plan.
- Sold Pursuant to a Rule 10b5-1 sales plan adopted on February 4, 2013.
- Represents the weighted average sales price for the shares. The range of prices for such sales was $64.00 to $64.20. The reporting person will provide upon request full information regarding the number of shares sold at each separate price.
- The shares subject to the option are fully vested and exercisable.